STOCK TITAN

Bristol Myers (NYSE: BMY) SVP details equity vesting, grants and tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bristol Myers Squibb SVP and Controller Phil M. Holzer reported multiple equity award transactions in company stock and units on March 10, 2026. He exercised market share units and performance shares covering 6,191 shares of common stock and received new grants of 5,031 market share units and 7,547 performance share units under long-term incentive programs.

The filing shows vesting and performance-based adjustments to prior awards, along with 1,358 common shares withheld at $60.13 per share to cover tax obligations. Following these compensation-related transactions, Holzer directly holds 17,362 shares of Bristol Myers Squibb common stock.

Positive

  • None.

Negative

  • None.
Insider Holzer Phil M
Role SVP and Controller
Type Security Shares Price Value
Exercise Market Share Units 811 $0.00 --
Exercise Market Share Units 768 $0.00 --
Exercise Performance Shares 4,612 $0.00 --
Grant/Award Market Share Units 5,031 $0.00 --
Grant/Award Performance Shares 7,547 $0.00 --
Exercise Common Stock, $0.10 par value 811 $0.00 --
Other Common Stock, $0.10 par value 91 $0.00 --
Tax Withholding Common Stock, $0.10 par value 261 $60.13 $16K
Exercise Common Stock, $0.10 par value 768 $0.00 --
Other Common Stock, $0.10 par value 83 $0.00 --
Tax Withholding Common Stock, $0.10 par value 248 $60.13 $15K
Exercise Common Stock, $0.10 par value 4,612 $0.00 --
Other Common Stock, $0.10 par value 2,264 $0.00 --
Tax Withholding Common Stock, $0.10 par value 849 $60.13 $51K
Holdings After Transaction: Market Share Units — 0 shares (Direct); Performance Shares — 0 shares (Direct); Common Stock, $0.10 par value — 15,778 shares (Direct)
Footnotes (1)
  1. Represents vesting of one-quarter of market share units granted on March 10, 2022. Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Shares withheld for payment of taxes upon vesting of awards. Represents vesting of one-quarter of market share units granted on March 10, 2023. Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Holzer Phil M

(Last) (First) (Middle)
BRISTOL-MYERS SQUIBB COMPANY
ROUTE 206 AND PROVINCE LINE ROAD

(Street)
PRINCETON NJ 08543

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRISTOL MYERS SQUIBB CO [ BMY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP and Controller
3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.10 par value 03/10/2026 M 811(1) A $0 15,778 D
Common Stock, $0.10 par value 03/10/2026 J 91(2) D $0 15,687 D
Common Stock, $0.10 par value 03/10/2026 F 261(3) D $60.13 15,426 D
Common Stock, $0.10 par value 03/10/2026 M 768(4) A $0 16,194 D
Common Stock, $0.10 par value 03/10/2026 J 83(2) D $0 16,111 D
Common Stock, $0.10 par value 03/10/2026 F 248(3) D $60.13 15,863 D
Common Stock, $0.10 par value 03/10/2026 M 4,612(5) A $0 20,475 D
Common Stock, $0.10 par value 03/10/2026 J 2,264(6) D $0 18,211 D
Common Stock, $0.10 par value 03/10/2026 F 849(3) D $60.13 17,362 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Market Share Units (7) 03/10/2026 M 811 (1) 03/10/2026 Common Stock, $0.10 par value 811 $0 0 D
Market Share Units (7) 03/10/2026 M 768 (4) 03/10/2027 Common Stock, $0.10 par value 768 $0 771 D
Performance Shares (8) 03/10/2026 M 4,612 (5) 03/10/2026 Common Stock, $0.10 par value 4,612 $0 0 D
Market Share Units (9) 03/10/2026 A 5,031 (10) 03/10/2029 Common Stock, $0.10 par value 5,031 $0 5,031 D
Performance Shares (11) 03/10/2026 A 7,547 (11) 03/10/2029 Common Stock, $0.10 par value 7,547 $0 7,547 D
Explanation of Responses:
1. Represents vesting of one-quarter of market share units granted on March 10, 2022.
2. Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.
3. Shares withheld for payment of taxes upon vesting of awards.
4. Represents vesting of one-quarter of market share units granted on March 10, 2023.
5. Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award.
6. Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board.
7. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.
8. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026.
9. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout.
10. These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board.
11. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board.
Remarks:
/s/ Amy Fallone, attorney-in-fact for Phil M. Holzer 03/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did BMY executive Phil M. Holzer report on this Form 4?

Phil M. Holzer reported vesting, exercises, and new grants of equity awards. The activity included market share units, performance shares, and related common stock, reflecting routine compensation events and long-term incentive programs rather than open-market buying or selling of Bristol Myers Squibb shares.

How many Bristol Myers Squibb shares did Phil M. Holzer acquire through equity award exercises?

Holzer exercised derivative awards tied to 6,191 shares of Bristol Myers Squibb common stock. These exercises stemmed from market share units and performance shares that vested based on pre-set performance metrics and award terms, converting into common stock as part of his compensation package.

What new equity awards did BMY grant to Phil M. Holzer in this filing?

Holzer received new derivative awards of 5,031 market share units and 7,547 performance share units. These awards are structured to convert into Bristol Myers Squibb common stock in future periods, subject to performance factors, time-based vesting, and Board certification of results under the company’s long-term incentive plans.

How many BMY shares were withheld for Phil M. Holzer’s tax obligations?

A total of 1,358 shares of Bristol Myers Squibb common stock were withheld to cover taxes. These tax-withholding transactions occurred at a share price of $60.13 and represent payment of tax liabilities on vesting rather than discretionary open-market sales by Holzer.

What is Phil M. Holzer’s Bristol Myers Squibb shareholding after these transactions?

After the reported transactions, Holzer directly holds 17,362 shares of Bristol Myers Squibb common stock. This figure reflects the net result of equity award exercises, performance adjustments, restructuring entries, and shares withheld for taxes on March 10, 2026.

How do BMY market share units and performance shares work in Holzer’s awards?

Market share units and performance shares convert into BMY common stock based on payout factors and performance criteria. Payouts depend on stock-price averages, total return, relative total shareholder return, and Board-certified performance results, with minimum and maximum payout factors defined in the award terms.